Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 715 $ 722
Restricted cash 1,696 1,880
Accounts and other receivables 606 369
Accounts receivable—related party 2 2
Inventory 123 243
Derivative assets 23 57
Other current assets 103 96
Total current assets 3,268 3,369
Non-current restricted cash 11 11
Property, plant and equipment, net 24,474 23,978
Debt issuance costs, net 138 149
Non-current derivative assets 81 34
Goodwill 77 77
Other non-current assets, net 292 288
Total assets 28,341 27,906
Current liabilities    
Accounts payable 21 25
Accrued liabilities 729 1,078
Deferred revenue 120 111
Derivative liabilities 25 37
Total current liabilities 895 1,251
Long-term debt, net 25,656 25,336
Non-current deferred revenue 0 1
Non-current derivative liabilities 9 19
Other non-current liabilities 74 59
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Outstanding: 237.9 million shares and 237.6 million shares at March 31, 2018 and December 31, 2017, respectively 1 1
Treasury stock: 12.6 million shares and 12.5 million shares at March 31, 2018 and December 31, 2017, respectively, at cost (392) (386)
Additional paid-in-capital 3,264 3,248
Accumulated deficit (4,270) (4,627)
Total stockholders’ deficit (1,397) (1,764)
Non-controlling interest 3,104 3,004
Total equity 1,707 1,240
Total liabilities and equity $ 28,341 $ 27,906